Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |